Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor

  • The PLOS ONE Staff

There are errors in the author affiliations. The affiliations should appear as shown here:

Carlyn A. Figueiredo1,2, Paulina C. Drohomyrecky4, Stephen D. S. McCarthy1,2, Danila Leontyev1, Xue-Zhong Ma1, Donald R. Branch1,2,3*☯, Shannon E. Dunn3,4,5*☯

1 Centre for Innovation, Canadian Blood Services, 67 College Toronto, Toronto, Ontario, Canada,

2 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada,

3 Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada,

4 Department of Immunology, University of Toronto, Toronto, Ontario, Canada,

5 Women’s College Research Institute, Toronto, Ontario, Canada

* Email: don.branch@utoronto.ca (DRB); sdunn@uhnresearch.ca (SED)

These authors contributed equally to this work.

Reference

  1. 1. Figueiredo CA, Drohomyrecky PC, McCarthy SDS, Leontyev D, Ma X-Z, et al. (2014) Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor. PLoS ONE 9(7): e101947

Citation: The PLOS ONE Staff (2014) Correction: Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor. PLoS ONE 9(11): e113001. https://doi.org/10.1371/journal.pone.0113001

Published: November 4, 2014

Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.